Skip to content

Study on the clinical effect of Mongolian medicine Manggari external application in the treatment of CSR

Study on the clinical effect of Mongolian medicine Manggari external application in the treatment of CSR

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000413
Enrollment
Unknown
Registered
2025-02-26
Start date
2025-02-14
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylosis radiculopathy

Interventions

Treatment group:Mongolian medicine Manggari external application
control group 2:Flurbiprofen Cataplasms
control group 1:Mecobalamin tablets+Ibuprofen Sustained-release Capsules+cervical electric traction

Sponsors

Xilingol League Mongolian Medical Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Meets the diagnostic criteria of Mongolian and Western medicine for cervical spondylotic radiculopathy; 2) Age range from 28 to 60 years old; 3) Clear awareness and good compliance able to fill out various survey forms as required. 4) I have a clear understanding of the entire process of this study and the uncertainties that exist. I agree to join this study and receive regular group treatment. I voluntarily sign an informed consent form; 5) Possible follow-up.

Exclusion criteria

Exclusion criteria: 1) Those who do not meet the above diagnosis and inclusion criteria; 2) Individuals with neck trauma or indications for surgery; 3) Combined with autoimmune and blood system diseases such as hepatitis B metabolic bone disease bone joint tuberculosis osteomyelitis severe osteoporosis etc; 4) Combining severe heart disease high fever coma systemic edema diffuse skin disease hemorrhagic disease malignant tumors etc; 5) Exclude upper limb pain caused by lesions other than the cervical spine (thoracic outlet syndrome shoulder periarthritis biceps brachii health inflammation tennis elbow carpal tunnel syndrome etc.); 6) Pregnant lactating women or those with extremely weak bodies.

Design outcomes

Primary

MeasureTime frame
IL--1ß;TNF-a;GSH-PX activity;MDA content;SOD activity;IL-6;

Secondary

MeasureTime frame
Northwick Park;visual analogue scale Analog scale;Changes in Mongolian Medicine Syndrome Differentiation;

Countries

China

Contacts

Public ContactSachula Baoyin

Xilingol League Mongolian Medical Hospital

295262793@qq.com15754930124

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026